Cargando…

Community-Acquired Pneumonia in Canada During Coronavirus Disease 2019

Dealing with coronavirus disease 2019 (COVID-19) has been a monumental test of medical skills and resources worldwide. The management of community-acquired pneumonia (CAP) can at times be difficult, but treating CAP in the setting of COVID-19 can be particularly trying and confusing and raises a num...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mandell, Lionel A, Zhanel, George G, Rotstein, Coleman, Muscedere, John, Loeb, Mark, Johnstone, Jennie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863085/ https://www.ncbi.nlm.nih.gov/pubmed/35211634 http://dx.doi.org/10.1093/ofid/ofac043

Ejemplares similares

Epidemiology and etiology of community-acquired pneumonia
por: Mandell, Lionel A.
Publicado: (2004)

Incidence and Predictors of Community-Acquired Pneumonia in Patients With Hematological Cancers Between 2016 and 2019( )
por: Certan, Maria, et al.
Publicado: (2022)

Epidemiology and Outcomes of Community-Acquired Escherichia coli Pneumonia
por: John, Teny M, et al.
Publicado: (2021)

Community-Acquired Pneumonia in the Immunocompromised Host: Epidemiology and Outcomes
por: Ramirez, Julio A, et al.
Publicado: (2023)

Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 Pneumonia
por: DiNubile, Mark J, et al.
Publicado: (2022)

Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia
por: Self, Wesley H., et al.
Publicado: (2017)

Normal Respiratory Flora as a Cause of Community-Acquired Pneumonia
por: Musher, Daniel M, et al.
Publicado: (2020)

Hepcidin and Ferritin Predict Microbial Etiology in Community-Acquired Pneumonia
por: Oppen, Kjersti, et al.
Publicado: (2021)

Clinical Features and Outcomes of Community-Acquired Pneumonia Caused by Haemophilus influenzae
por: Shoar, Saeed, et al.
Publicado: (2021)

Lymphopenia Is Associated With Poor Outcomes of Patients With Community-Acquired Pneumonia and Sepsis
por: Cilloniz, Catia, et al.
Publicado: (2021)

Molecular Detection and Characterization of Mycoplasma pneumoniae Among Patients Hospitalized With Community-Acquired Pneumonia in the United States
por: Diaz, Maureen H., et al.
Publicado: (2015)

Development of an Electronic Algorithm to Identify in Real Time Adults Hospitalized With Suspected Community-Acquired Pneumonia
por: Jones, George, et al.
Publicado: (2021)

Feasibility and Acceptability of Community Coronavirus Disease 2019 Testing Strategies (FACTS) in a University Setting
por: Hirst, Jennifer A, et al.
Publicado: (2021)

Incidence, Etiology, and Outcomes of Community-Acquired Pneumonia: A Population-Based Study
por: Bjarnason, Agnar, et al.
Publicado: (2018)

Antibiotic Use and Outcomes in Young Children Hospitalized With Uncomplicated Community-Acquired Pneumonia
por: Hofto, Meghan E, et al.
Publicado: (2022)

Improved Diagnostics Help to Identify Clinical Features and Biomarkers That Predict Mycoplasma pneumoniae Community-acquired Pneumonia in Children
por: Meyer Sauteur, Patrick M, et al.
Publicado: (2019)

Effects of a Syndrome-Specific Antibiotic Stewardship Intervention for Inpatient Community-Acquired Pneumonia
por: Haas, Michelle K., et al.
Publicado: (2016)

Clinical Manifestation and Neonatal Outcomes of Pregnant Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
por: Xu, Shuang, et al.
Publicado: (2020)

Hospital-Acquired Bloodstream Infections in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019): Association With Immunosuppressive Therapies
por: Khatri, Akshay, et al.
Publicado: (2021)

Opaganib in Coronavirus Disease 2019 Pneumonia: Results of a Randomized, Placebo-Controlled Phase 2a Trial
por: Winthrop, Kevin L, et al.
Publicado: (2022)

Impact of Streptococcus pneumoniae Urinary Antigen Testing in Patients With Community-Acquired Pneumonia Admitted Within a Large Academic Health System
por: Greenfield, Adam, et al.
Publicado: (2021)

Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019: A Phase 2a Trial
por: Sasson, Jennifer, et al.
Publicado: (2022)

Low Levels of Immunoglobulins and Mannose-Binding Lectin Are Not Associated With Etiology, Severity, or Outcome in Community-Acquired Pneumonia
por: Siljan, William W, et al.
Publicado: (2018)

Bacteremic Community-Acquired Pneumonia in Ethiopian Children: Etiology, Antibiotic Resistance, Risk Factors, and Clinical Outcome
por: Negash, Abel Abera, et al.
Publicado: (2019)

A Pathway for Community-Acquired Pneumonia With Rapid Conversion to Oral Therapy Improves Health Care Value
por: Ciarkowski, Claire E, et al.
Publicado: (2020)

Risk factors for isolation of multi-drug resistant organisms in coronavirus disease 2019 pneumonia: A multicenter study
por: Son, Hyo-Ju, et al.
Publicado: (2021)

Adherence to Treatment Guideline Improves Patient Outcomes in a Prospective Cohort of Adults Hospitalized for Community-Acquired Pneumonia
por: Lui, Grace, et al.
Publicado: (2020)

Host Inflammatory Biomarkers of Disease Severity in Pediatric Community-Acquired Pneumonia: A Systematic Review and Meta-analysis
por: Fernandes, Catarina D, et al.
Publicado: (2019)

Telithromycin in the treatment of acute bacterial sinusitis, acute exacerbations of chronic bronchitis, and community-acquired pneumonia
por: Zhanel, George G, et al.
Publicado: (2006)

Differentiating Between 2019 Novel Coronavirus Pneumonia and Influenza Using a Nonspecific Laboratory Marker–Based Dynamic Nomogram
por: Wang, Linghang, et al.
Publicado: (2020)

Coronavirus Disease 2019–Associated Invasive Fungal Infection
por: Baddley, John W, et al.
Publicado: (2021)

A Phase 3 Study to Compare Delafloxacin With Moxifloxacin for the Treatment of Adults With Community-Acquired Bacterial Pneumonia (DEFINE-CABP)
por: Horcajada, Juan P, et al.
Publicado: (2019)

Influenza and Bacterial Coinfection in Adults With Community-Acquired Pneumonia Admitted to Conventional Wards: Risk Factors, Clinical Features, and Outcomes
por: Abelenda-Alonso, Gabriela, et al.
Publicado: (2020)

Efficacy of Omadacycline Versus Moxifloxacin in the Treatment of Community-Acquired Bacterial Pneumonia by Disease Severity: Results From the OPTIC Study
por: Ramirez, Julio, et al.
Publicado: (2021)

A Statewide Collaborative Quality Initiative to Improve Antibiotic Duration and Outcomes in Patients Hospitalized With Uncomplicated Community-Acquired Pneumonia
por: Vaughn, Valerie M, et al.
Publicado: (2021)

Etiology and Impact of Coinfections in Children Hospitalized With Community-Acquired Pneumonia
por: Nolan, Vikki G, et al.
Publicado: (2018)

Viral Infection in Adults Hospitalized With Community-Acquired Pneumonia: Prevalence, Pathogens, and Presentation
por: Johnstone, Jennie, et al.
Publicado: (2008)

Investigating Epidemiologic and Molecular Links Between Patients With Community- and Hospital-Acquired Influenza A: 2017–2018 and 2019–2020, Michigan
por: Wan, Tiffany, et al.
Publicado: (2023)

Antibiotic Treatment Duration for Community-Acquired Pneumonia in Outpatient Children in High-Income Countries—A Systematic Review and Meta-Analysis
por: Kuitunen, Ilari, et al.
Publicado: (2022)

Dying at Home Due to Coronavirus Disease 2019
por: Edwards, Jessie K, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k3ijgcer8tn0ure8bum4lu1pl1